Fundraising FoxLepu Biopharm
1 known investors
Find your way into Lepu Biopharm
Sign up to see every warm intro you have to Lepu Biopharm
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Lepu Biopharm team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Lepu Biopharma is a Chinese biopharmaceutical company that develops antibody-drug conjugates (ADCs) and other oncology drugs, including the CD20-targeting ADC MRG001 for relapsed/refractory diffuse large B-cell lymphoma. Its candidate drugs undergo clinical trials and regulatory review by China's National Medical Products Administration.
Investors · 1
Frequently asked questions
- What does Lepu Biopharm do?
- Lepu Biopharma is a Chinese biopharmaceutical company that develops antibody-drug conjugates (ADCs) and other oncology drugs, including the CD20-targeting ADC MRG001 for relapsed/refractory diffuse large B-cell lymphoma. Its candidate drugs undergo clinical trials and regulatory review by China's National Medical Products Administration.
- Who are Lepu Biopharm's investors?
- Lepu Biopharm's investors include Vivo Capital.